Newborn Screening Services for in support of Naval Hospital Jacksonville, Florida (NH Jacksonville), Naval Hospital Guantanamo Bay, Cuba (USNH GTMO), Naval Medical Center Camp Lejeune, NC (NMCCL) and Naval Medical Center Portsmouth, Virginia (NMCP)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA) is soliciting proposals for Newborn Screening Services to support military beneficiaries at Naval Hospital Jacksonville, FL; Naval Hospital Guantanamo Bay, Cuba; Naval Medical Center Camp Lejeune, NC; and Naval Medical Center Portsmouth, VA. This is a sole source acquisition for firm fixed-price contracts. Proposals are due March 26, 2026, at 12:00 PM EST.
Scope of Work
The contractor will provide comprehensive non-personal Newborn Screening Services, including:
- Supply of specimen collection kits.
- Laboratory analysis of dried blood spot samples.
- Timely electronic reporting of results.
- Testing for all conditions required by the Department of Health and Human Services Recommended Uniform Screening Panel (RUSP).
- Provision of courier services for sample transport.
- Training and technical assistance to hospital staff.
Services will be performed off-site at designated reference laboratories in Florida, North Carolina, and Virginia. Estimated annual birth volumes are 600 for Jacksonville, 15 for Guantanamo Bay, 1560 for Camp Lejeune, and 2400 for Portsmouth.
Contract Details
- Contract Type: Firm Fixed Price
- Period of Performance: A base period (May 1, 2026 - April 30, 2027) and up to five option periods, extending through October 31, 2031.
- NAICS Code: 621511 (Medical Laboratories) with a $41.5M size standard.
- Set-Aside: This acquisition is not set-aside for small business concerns.
- Subcontracting: A 5% small business subcontracting goal is required.
Submission & Evaluation
- Submission Deadline: March 26, 2026, 12:00 PM EST.
- Submission Method: Electronically via email to the Contracting Officer and Contract Specialist.
- Proposal Format: Two volumes: Volume I (Administrative) and Volume II (Price).
- Evaluation: Award will be made without discussions, based on an equal consideration of non-price and price factors. Offers must pass all elements of Volume I and have a reasonable price in Volume II.
- Key Requirements: Offerors must be registered in SAM, be CLIA-certified, state-licensed, and accredited (e.g., CAP).
Contact Information
- Primary: Brittany Belsches (brittany.n.belsches.civ@health.mil, 301-619-9116)
- Secondary: Mary Shifflett (mary.e.shifflett2.civ@health.mil, 301-610-6160)